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The clinical and parasitological characteristics of the rst naturally acquired malarial infection have rarely been
documented in humans. When 243 migrants from non-endemic Java were followed from the day of their arrival
in Indonesian Papua, 217 (89%) were found to become infected with Plasmodium falciparum and/or P. vivax
before they were lost to follow-up. The incidence of malarial infection in the children investigated (who were
aged 6–10 years) was indistinguishable from that in the adults (aged >20 years), with 1.10 and 1.14 P. falciparum
infections/person-year (relative risk=0.97; 95% condence interval=0.72–1.29) and 1.47 and 1.49 P. vivax
infections/person-year (relative risk=0.99; 95% condence interval=0.72–1.29), respectively. During their
rst infections, the children had higher P. falciparum parasitaemias than the adults (with geometric means of 1318
and 759 parasites/ml, respectively; P=0.04) but similar P. vivax parasitaemias (with geometric means of 355 and
331 parasites/ml, respectively; P=0.76). At rst infection, 56% of the subjects were febrile and 90% complained
of symptoms. There were no diVerences between children and adults with respect to these two parameters, either
for P. falciparum or P. vivax. These ndings indicate that, with promptly diagnosed and treated uncomplicated
malaria, migrant children and adults in north–eastern Indonesian Papua have an equal risk of malarial infection
and of disease following their rst infections with P. falciparum and P. vivax.
The results of therapeutic or experimental Malaria therapy early in the 20th century
cured many thousands of neurosyphilis caseschallenge of adult volunteers constitute most
and studies of these infections profoundlyof the detailed body of clinical knowledge
improved our understanding of the clinicalof acute malaria in non-immune people.
aspects of malaria (Von Juaregg, 1922).
During World War II, the strategic urgency
Address enquiries to: J. K. Baird, U.S. Naval Medical for new antimalarial drugs prompted clinical
Research Center Detachment, American Embassy Lima,
studies in soldiers and prison inmates (CollinsAPO AA 34031-3800, U.S.A.
and JeVery, 1999). In more recent years, theE-mail: baird@nmrcd.med.navy.mil; fax: +51 1 561
3042. results of a few experimental challenges have
*The opinions and assertions contained herein are those
provided much more detailed information on
of the authors and do not purport to reect those of
the blood-chemistry, cell-prole and immuno-the United States Navy and Department of Defense
and the Ministry of Health of the Republic of Indonesia. logical aspects of malaria (Herrington et al.,
Reprint requests should be sent to the Commanding 1991; Church et al., 1997; HoVman et al.,
OYcer, United States Navy Medical Research Unit #2,
2002). These studies have, however, shedAmerican Embassy Jakarta, FPO AP 96520-8132,U.S.A.
(for the attention of the Publication OYce). no light on malarial infection and disease in
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children. In experimental challenge, more- Observations on travellers with malaria, on the
over, it is diYcult to mimic the eVects infections occurring during malaria epidemics,
of treatment-seeking behaviour or natural and during a retrospective investigation of
challenge by wild strains of the parasite. another transmigration settlement also indi-
Although epidemics of the disease may cated that malaria-naṏve adults are at higher
oVer opportunities for investigating primary risk of severe disease than malaria-naṏve
malaria in human populations, there appear children (Gill, 1936; Bastien, 1987; Greenberg
to have been no detailed clinical and para- and Lobel, 1990; Buck and Eichenlaub, 1994;
sitological observations published on primary Some, 1994; Baird et al., 2003). It seems
infection during malaria epidemics. possible that intrinsic age-related diVerences
The organized relocation of families from in the immune response to primary infection
Java to Indonesian Papua (formerly known form the basis of this adult susceptibility to
as Irian Jaya), at various times between severe disease. In the present study, to explore
1965 and 1997, resulted in non-immune this possibility, the rst smear-conrmed
people of all ages being abruptly exposed P. falciparum or P. vivax infections suVered
to hyper- and holo-endemic malaria. An by malaria-naṏve Javanese transmigrants to
aggressive DDT-spraying campaign in the Indonesian Papua, and the disease associated
1950s eradicated endemic malaria from East with each of these primary infections, were
and West Java (Atmosoedjono, 1990; Arbani, investigated.
1992) and left only a few scattered foci of
hypo-endemic risk in Central Java (Baird
et al., 1996). The unpublished records of
SUBJECTS AND METHODS
the Indonesian Ministry of Health show
that, between 1969 and 1996, the mean
Study Site
annual incidence of malaria throughout Java
The study site was the transmigration village
and Bali was only 0.03 case/1000 residents.
known as Satuan Permukiman (SettlementThus, the migrants investigated in the pre-
Unit) 2 (SP2), which lies, near the Pacicsent study (with a mean age of 25 years of
Ocean, in north–eastern Papua, Indonesia.age and screened against residence on other
The village, which has already been describedislands or in a known focus of malaria risk
in detail by Krisin et al. (2003), covers anon Java) arrived in Indonesian Papua having
area of about 4 km2. It had 1428 residents inan estimated individual risk of just 0.075%
1996, most (78.3%) of whom were migrantsfor a single prior episode of malaria. In
from Java. The Indonesian Department ofnorth–eastern Papua, in contrast, the risk
Transmigration constructed SP2 in 1995of malarial infection within 3–6 months is
and 1996. The housing, of uniform wood-100% (Jones et al., 1994; FryauV et al.,
plank and tin-roof construction, presented1995; Ohrt et al., 1997; Taylor et al., 1999;
few obstacles to host-seeking mosquitoes.Baird et al., 2001).
Hyper- to holo-endemic malaria, transmittedIn a retrospective study of one trans-
by the Anopheles punctulatus complex ofmigration community in Indonesian Papua, a
mosquitoes, occurs throughout most of north–high risk of evacuation with severe, Plasmodium
eastern Papua. Almost all of the malaria isfalciparum malaria during the rst 6 months
caused by P. falciparum or P. vivax, with onlywas documented (Baird et al., 1998). The
occasional infections by P. malariae and veryrisk of evacuation was markedly higher for
rare infections by P. ovale (Baird et al., 1990,the adult migrants than for their children
1991). In compliance with the regulations[relative risk=2.7; 95% condence interval
of the Department of Transmigration, new-(CI)=1.9–3.8], even though the risk of
comers to SP2 received weekly chloroquineinfection with P. falciparum appeared similar
for all age-groups (Baird et al., 1991, 1995). (5 mg/kg) for 12 weeks, as chemoprophylaxis.
PRIMARY MALARIA IN NON-IMMUNE MIGRANTS 567
Compliance with this regimen was supervised The analysis here is limited to each sub-
among the study subjects, to ensure uniform ject’s rst infection with P. falciparum and his
usage of chloroquine across the cohort. The or her rst infection with P. vivax. Subjects
results of previous studies in similar settings parasitaemic rst with P. falciparum were
indicated, however, that chloroquine was no treated and still considered at risk for P. vivax,
more eVective than placebo in preventing and vice versa. Owing to the lingering sup-
infection by P. falciparum or P. vivax (Baird pression of parasitaemia by the administered
et al., 1995; FryauV et al., 1995). therapy, however, the 4 weeks following the
rst treatment for malarial infection were not
counted as time at risk of infection by the
Follow-up other species. Individual subjects only ceased
A research station and clinic were established contributing ‘person-time at risk’ after having
in SP2 in July 1996, to enable a longitudinal experienced infection by both P. falciparum
study of adults (aged >20 years) and children and P. vivax. Subjects found smear-positive
(aged 6–12 years) who had migrated from were given directly observed treatment with
non-malarious areas of Java. The study either chloroquine (25 mg/kg, in three doses
protocol was reviewed and approved by over 48 h) or meoquine (25 mg/kg, as a single
the relevant American and Indonesian com- dose) according to a randomized (1:1) assign-
mittees for the protection of human sub- ment at enrolment. Non-pregnant subjects
jects, and informed consent was obtained in positive for P. vivax also received primaquine
accordance with the United States Navy’s
(30 mg daily for 14 days).
regulations governing the use of human sub-
jects in medical research (SECNAVINST
3900.39B). A detailed description of the
Classication of Infections
subjects and the methods of follow-up is
First infections were classied as febrile or
available elsewhere (Krisin et al., 2003). In
afebrile, a febrile case having a patent para-
brief, 243 subjects were enrolled on their day
sitaemia and a documented axillary temper-
of arrival at SP2 (between 25 August and
ature of >37.5°C. The rst parasitaemias
3 October 1996) and within 48 h of their
of 22 subjects were only detected whenarrival in Indonesian Papua. This cohort was
the routine bloodsmears produced biweeklyfollowed for 33 months. The regimen of
were checked. The axillary temperature of afollow-up included physical and laboratory
subject from whom a routine blood sampleexaminations on enrolment and the pro-
was being collected was not recorded if thatduction of routine bloodsmears and the
subject did not complain of illness at thatrecording of axillary temperatures every
time. Any complaint of illness or notice of2 weeks (or whenever the subject complained
fever would have prompted the subject’sof symptoms consistent with malaria). A
referral for medical attention, the productionmember of the research team visited each
and examination of a non-routine bloodsmearsubject in his or her home every other day,
and the recording of the subject’s axillaryto ascertain the subject’s health status by
temperature. Each subject found parasitaemica standardized procedure. The intention
only as the result of the examination of awas to detect all episodes of clinical illness.
routine blood sample was therefore assumedTechnicians certied as expert in the diagnosis
to have been afebrile and asymptomatic atof malaria by microscopical examination of
the time that sample had been collected.Giemsa-stained thick bloodsmears provided
First infections were also classied asdiagnostic services. A thick smear was only
symptomatic or asymptomatic, on the basisconsidered negative if a technician checking
of parasitaemia concurrent with a subject200 elds at a magnication of ×1000 failed
to detect a single malarial parasite. seeking medical attention or complaining of
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symptoms consistent with malaria (i.e. fever, weeks for the 19 adults. One adult subject
chills, headache, nausea, vomiting, myalgia, never developed parasitaemia during all 33
malaise and/or diarrhoea) during a home months of follow-up.
visit. The Figure illustrates the cumulative risk
of infection by P. falciparum and P. vivax
among children and adults. The mean time
Statistical Analysis to rst parasitaemia was essentially identical
Risk of infection was measured as both for P. falciparum (185 days, with a range
the mean time (the mean number of days 11–856 days) and P. vivax (190 days,
from arrival ) to the rst slide-conrmed
with a range 14–901 days; P=0.729). The
parasitaemia and the incidence of infection.
times to rst parasitaemia were essentially
Incidence was calculated as the number of
the same for the children and adults, both
infections divided by the number of person-
for P. falciparum (P=0.57) and P. vivax
years at risk. The results were expressed
(P = 0.29). Likewise, the incidence of
statistically as means or frequencies, and
infection was similar among the children
generally analysed using unpaired Student’s
and adults, both for P. falciparum (1.10
t-tests or Mantel–Haenszel tests. A x2 test
infections/child-year v. 1.14 infections/
was used to assess diVerences in calculated
adult-year; RR=0.97; CI=0.72–1.29) and
proportions. A P-value of å0.05 was con-
for P. vivax (1.47 infections/child-year v.
sidered indicative of statistical signicance.
1.49 infections/adult-year; RR=0.99; CI=
Where appropriate, a relative risk (RR) or
0.75–1.30). Children and adults were atodds ratio (OR) and its 95% condence
equal risk of infection with P. falciparum orinterval (CI) were calculated. Kaplan–Meier
P. vivax. Children, however, had generallysurvival analysis was used to calculate the
higher rst P. falciparum parasitaemias thancumulative probability curves, in weeks to the
the adults (with geometric mean counts ofrst malarial infection. All the analyses were
1318 v. 759 parasites/ml; P=0.04), althoughcarried out using version 8.0 of the SPSS
the levels of the rst P. vivax parasitaemias(SPSS Inc., Chicago, IL) or version 6.0 of
were similar in the children and adultsthe Epi Info (Centers for Disease Control and
investigated (with geometric mean countsPrevention, Atlanta, GA) software packages.
of 355 v. 331 parasites/ml; P = 0.76). In
both age-groups, the P. falciparum counts
were signicantly higher than the P. vivaxRESULTS
(P<0.001).
At rst infection with P. falciparum orTable 1 presents the demographic and para-
P. vivax, 56% of the subjects were febrile andsitological data collected, stratied by the
90% complained of malaria-like symptomstwo age-groups. The overall ratio of males
(Table 1). With P. falciparum, there was noto females who participated in the study was
signicant diVerence between the adults andapproximately 2:1 (163:80). Almost all of
children in the risk of fever (OR=1.19; P=the subjects — 93% (90/97) of the children
0.60), or complaint of illness (OR=0.55;and 87% (127/146) of the adults (RR=1.07;
P=0.20). With P. vivax, similarly, there wasCI=0.98–1.16) — experienced at least
no signicant diVerence between adults andone malarial infection over the observation
children in the frequency of associated feverperiod. Twenty-ve of the 26 subjects who
(OR=1.29; P=0.40) or complaint of ill-were never found parasitaemic were lost to
ness (OR=0.77; P=0.59). Between thefollow-up after deciding to return to Java;
two species, no diVerences appeared in thethe median times these 26 subjects were
likelihood of fever (OR=1.35; P=0.16) orfollowed were 11 (range=2–29) weeks for
the seven children and 20 (range=2–144) reported illness (OR=0.84; P=0.62).
PRIMARY MALARIA IN NON-IMMUNE MIGRANTS 569
T
A
B
L
E
1
.
S
u
m
m
a
ry
o
f
th
e
d
em
og
ra
p
h
ic
a
n
d
p
a
ra
si
to
lo
g
ic
a
l
d
a
ta
o
n
th
e
st
u
d
y
co
h
o
rt
O
d
d
s
ra
ti
o
a
n
d
R
R
an
d
V
a
ri
ab
le
C
h
il
d
re
n
A
d
u
lt
s
A
ll
su
b
je
c
ts
(9
5
%
C
I)
(9
5
%
C
I)
P
N
o
.
o
f
su
b
je
ct
s
e
n
ro
ll
ed
9
7
1
4
6
2
4
3
M
ea
n
a
g
e
a
n
d
(r
an
g
e)
(
y
ea
rs
)
9
.2
(6
–
1
2
)
3
1
.8
(2
0
–
5
8
)
2
2
.8
(6
–
5
8
)
M
ed
ia
n
a
g
e
(
y
ea
rs
)
9
3
1
2
6
N
o
.
o
f
m
al
e
s:
fe
m
a
le
s
6
3
:3
4
1
0
0
:4
6
1
6
3
:8
0
%
o
f
su
b
je
c
t
s
a
n
d
(n
o
.
o
f
su
b
je
c
t
s/
n
o
.
in
v
e
st
ig
a
t
e
d
)
L
o
st
to
fo
ll
o
w
-u
p
7
(7
/9
7
)
1
2
(1
8
/1
4
6
)
0
.5
5
(0
.2
0
–
1
.4
8
)
P
ri
m
a
ry
in
fe
c
ti
o
n
w
it
h
P
.
fa
lc
ip
a
ru
m
4
4
(4
3
/9
7
)
4
4
(6
4
/1
4
6
)
1
.0
2
(0
.5
9
–
1
.7
7
)
F
ir
st
P
.
fa
lc
ip
a
ru
m
in
fe
c
ti
o
n
af
te
r
P
.
v
iv
a
x
3
6
(3
5
/9
7
)
3
0
(4
5
/1
4
6
)
1
.2
7
(0
.7
1
–
2
.2
6
)
P
ri
m
a
ry
in
fe
c
ti
o
n
w
it
h
P
.
v
iv
a
x
4
9
(4
7
/9
7
)
4
9
(7
1
/1
4
6
)
0
.9
9
(0
.5
7
–
1
.7
1
)
F
ir
st
P
.
v
iv
a
x
in
fe
c
ti
o
n
a
ft
er
P
.
fa
lc
ip
a
ru
m
4
0
(3
9
/9
7
)
3
4
(5
0
/1
4
6
)
1
.2
9
(0
.7
3
–
2
.2
7
)
F
eb
ri
le
o
n

rs
t
P
.
fa
lc
ip
a
ru
m
in
fe
ct
io
n
6
2
.1
(4
1
/6
6
)
5
8
.0
(5
8
/1
0
0
)
1
.1
9
(0
.6
0
–
2
.3
6
)
C
o
m
p
la
in
in
g
o
f
il
ln
e
ss
o
n

rs
t
P
.
fa
lc
ip
a
ru
m
in
fe
c
ti
o
n
8
5
.9
(6
7
/7
8
)
9
1
.7
(1
0
0
/1
0
9
)
0
.5
5
(0
.2
0
–
1
.5
2
)
F
eb
ri
le
o
n

rs
t
P
.
v
iv
a
x
in
fe
ct
io
n
5
5
.8
4
3
/7
7
)
4
9
.5
(5
3
/1
0
7
)
1
.2
9
(0
.6
9
–
2
.4
2
)
C
o
m
p
la
in
in
g
o
f
il
ln
e
ss
o
n

rs
t
P
.
v
iv
a
x
in
fe
ct
io
n
8
9
.6
(7
7
/8
6
)
9
1
.7
(1
1
1
/1
2
1
)
0
.7
7
(0
.2
7
–
2
.1
8
)
g
e
o
m
e
t
r
ic
m
e
a
n
l
e
v
e
l
o
f
p
a
r
a
si
t
a
e
m
ia
a
n
d
(9
5
%
C
I)
(
p
a
ra
si
te
s/
m
l)
F
ir
st
P
.
fa
lc
ip
a
ru
m
in
fe
c
ti
o
n
1
3
4
8
(8
6
0
–
2
1
1
4
)
7
5
5
(5
3
9
–
1
0
5
9
)
0
.4
1
F
ir
st
P
.
v
iv
a
x
in
fe
c
ti
o
n
3
5
4
(2
5
5
–
4
9
1
)
3
3
0
(2
5
0
–
4
3
8
)
0
.7
6
m
e
a
n
t
im
e
a
n
d
(r
a
n
g
e
)
t
o
f
ir
st
in
f
e
c
t
io
n
(d
a
y
s)
W
it
h
P
.
fa
lc
ip
a
ru
m
1
9
2
(1
4
–
5
1
5
)
1
8
0
(2
1
–
9
0
1
)
0
.5
7
W
it
h
P
.
v
iv
a
x
2
0
0
1
1
–
7
6
4
)
1
8
2
(1
8
–
8
5
6
)
0
.2
9
in
c
id
e
n
c
e
(i
n
fe
ct
io
n
s/
p
er
so
n
-y
e
a
r)
P
la
sm
o
d
iu
m
fa
lc
ip
a
ru
m
1
.1
1
.1
4
0
.9
7
(0
.7
2
–
1
.2
9
)
P
la
sm
o
d
iu
m
v
iv
a
x
1
.4
7
1
.4
9
0
.9
9
(0
.7
5
–
1
.3
0
)
C
I,
C
o
n

d
en
c
e
in
te
rv
a
l.
570 BARCUS ET AL.
FIG. The weekly cumulative incidences of Plasmodium falciparum parasitaemia among adult (s ) and child
(d) migrants from Java, and the corresponding data for P. vivax parasitaemia among the same adults (h ) and
children (j ), beginning on the day the migrants arrived at SP2 in Papua, Indonesia.
The clinical characteristics of the rst plaint of illness of 0.66 (P=0.54) and 1.15
(P=0.84), respectively. For P. vivax pre-infections with P. falciparum or P. vivax were
also compared on the basis of prior exposure ceded by P. falciparum, the OR for fever
were 1.05 (P=0.92) in children and 2.09(in one or more infections) to the other
species of parasite. Of all the ‘rst’ infections (P=0.06) in adults whereas those for com-
plaint of illness were 4.92 (P=0.07) inconsidered, 55% of those in children and
59% of those in adults represented primary children and 1.47 (P=0.56) in adults.
exposures to malaria. The remainder of the
‘rst’ infections had been preceded by at
DISCUSSIONleast one infection with the other species
and were therefore considered secondary
exposures to malaria. The risk of fever The observations reported here demonstrate
the high risk of disease with rst exposureor complaint of illness appeared the same
for the primary and secondary exposures to P. falciparum or P. vivax among Javanese
migrants to north–eastern Papua, Indonesia.(Tables 2 and 3). For P. falciparum preceded
by P. vivax, the OR for fever were 0.82 As their rst P. falciparum or P. vivax para-
sitaemias became patent, more than half of(P=0.71) in children and 0.60 (P=0.25)
in adults, with corresponding OR for com- the subjects were found febrile and >90%
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TABLE 2. EVect of prior exposure to Plasmodium vivax upon risk of fever or illness with primary exposure to P. falciparum
Prior Plasmodium vivax (no. of subjects)?
Yes No Odds ratio and (95% CI)
Febrile 41 58 1.96 (0.87–4.44)
Afebrile 13 36
Complaint of illness 66 95 1.04 (0.37–2.98)
No complaint of illness 8 12
CI, Condence interval.
TABLE 3. EVect of prior exposure to Plasmodium falciparum upon risk of fever or illness with primary exposure to P. vivax
Prior Plasmodium falciparum (no. of subjects)?
Yes No Odds ratio and (95% CI)
Febrile 39 57 0.65 (0.35–1.22)
Afebrile 45 43
Complaint of illness 77 111 0.40 (0.14–1.17)
No complaint of illness 12 7
CI, Condence interval.
complained of being ill. The cyclical nature the rates measured in the nearby settlement
villages of SP4, SP5 and SP6 during 1999of fever caused by malarial parasites may
explain why the prevalence of fever (detected and 2000 (Baird et al., 2001).
Risk of infection may be confoundedat a single point in each infection) was lower
than the frequency of reported illness. The by diVerential risk of exposure to biting
anophelines. The degree of this confoundingpossibility that the 12 weeks of chloroquine
prophylaxis given to new migrants caused largely depends upon behaviours that put
mosquitoes in contact with humans. Peoplesignicant confounding of the risks of fever
or complaint of illness was discounted, who are particularly likely to enter forests,
such as loggers, are more likely to be bittenbecause 336 of the 394 rst infections
investigated occurred after this prophylaxis by species of anopheline mosquito that ‘prefer’
forest habitats. Children who tend to remainhad ended. The slight lags in the develop-
ment of the rst detected P. falciparum in the village setting are at relatively low risk
of being bitten by these mosquito species.and rst detected P. vivax parasitaemias
(see Figure) may, however, be attributed In earlier cross-sectional studies of Javanese
migrants to Indonesian Papua, the risk ofto the suppression of the parasitaemias by
the chloroquine. The overall incidences parasitaemia and disease appeared to fall for
adults, but not children, after several yearsrecorded in SP2, of 1.1 P. falciparum
infections and 1.5 P. vivax infections/ (Baird et al., 1991, 1993). In these studies,
the possibility that the adults were simply atperson-year, are appreciably lower than the
rates — of 2.5–3.3 P. falciparum infections higher risk of exposure than the children,
because adult-specic behaviours, such asand 2.3–2.5 P. vivax infections/person-
year — measured in other studies in the Arso logging, increased the risk of being bitten by
a potential vector, was discounted. The localarea of north–eastern Papua ( Jones et al.,
1994; Ohrt et al., 1997; Taylor et al., 1999). vectors — mosquitoes of the An. punctulatus
complex — avoid forest and prefer the open,They are, however, essentially the same as
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sun-lit areas to be found in transmigration immune response to infection by another
species. In the present SP2 cohort, however,villages. It was therefore assumed that trans-
migrant infection with P. falciparum or the risk of fever or complaint of illness when
rst infected with P. falciparum was similarP. vivax occurred predominantly in the
village setting, where children and adults whether there had been a prior infection with
P. vivax or not, and vice versa. This waswere at equal risk. Past (Baird et al., 1991,
1993) and present observations (Table 1), true among both children and adults. The
SP2 cohort, however, would not allow theparticularly the similar prevalences of para-
sitaemia and incidences of infection in adult detection of functional cross-protection
from severe disease.and child transmigrants during the rst few
months of their exposure, support this view. In summary, fever and complaints of ill-
ness occurred among most Javanese migrantsIn the present study, children and adults
appeared uniformly susceptible to disease to Papua experiencing rst exposure to
P. falciparum or P. vivax. For each Plasmodiumwith primary P. falciparum or P. vivax
infection, the associated risks of fever or com- species, neither the host’s age nor prior
exposure to the other species confoundedplaints of illness being essentially identical
for the two age-groups. This observation the risk of fever or illness. The nding of
equal incidences of infection in children andappears to conict with that made in an
earlier retrospective analysis of the risks of adults supports the assumption, of similar
exposure to infection across all age-groups,severe disease among migrants at Arso PIR
IV (Baird et al., 1998), but essential diVer- made in earlier studies on the patterns of
parasitaemia and disease in migrants toences in methods almost certainly account
for this discrepancy. In the earlier study in Indonesian Papua.
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